Justin  Lathia,  PhD

Justin Lathia, PhD

Associate Staff

Lerner Research Institute, 9500 Euclid Avenue, Cleveland, Ohio 44195
Location: NN1-25A
Email: lathiaj@ccf.org
Phone: (216) 445-7475
Fax: (216) 444-9404

 


Our two main areas of interest involve using in vivo imaging models to interrogate the tumor microenvironment and examining communication mechanisms used by cancer stem cell to promote their maintenance. Currently our work is focused on malignant brain tumors but our technology and interests are applicable to many other tumor types.

In vivo imaging
To achieve this goal, we rely mainly on in vivo two photon laser scanning microscopy. We have models in which we transplant labeled human brain tumor cells and can watch tumor development in real time. We can also evaluate tumor cell behavior in slice cultures, which allows us to evaluate the molecular contribution of the microenvironment and more appropriately model the human tumor microenvironment. We are in the process of adapting a currently used brain tumor model to be more amendable to in vivo imaging. We also have active collaborations imaging neuroinflammatory processes.

Communication mechanisms
Cells are driven by two main cues an intrinsic and extrinsic program. Within the extrinsic programs, we are interested in how tumor cells interact with one another and the specialized extracellular matrix present in the tumor microenvironment. These interactions drive stem cell maintenance and may represent a new therapeutic angle for tumors.

In other words ...

Cancer is a disease defined by complexity and it has recently been appreciated that many lethal tumors contain a high degree of cellular heterogeneity. Moreover, tumor cells are organized in a cellular hierarchy, with a cancer stem cell at the apex. Cancer stem cells have been characterized in a variety of cancers, including malignant brain tumors, and have been shown to be responsible for tumor formation and therapeutic resistance. Our main interest is how cancer stem cells from malignant brain tumors interact with their surrounding microenvironment, which provides signals to preserve the malignancy of these cells.  Specifically, we are interested in cell to cell communication mechanisms as these will help better define the biology of this population and may serve as potent therapies. To fully appreciate cancer stem cell interactions in the appropriate microenvironment, we are developing imaging models to study the communication in real time.


Tyler  Alban  Tyler Alban
Graduate Student
Location:NB1-25
Phone:(216) 445-7632
albant@ccf.org
Defne  Bayik  PhD Defne Bayik, PhD
Postdoctoral Fellow
Location:NN1-25
Phone:(216) 445-7632
watsond3@ccf.org
Anastasia  Chumakova  MD Anastasia Chumakova, MD
Fellow
Location:NN1-25
Phone:(216) 445-7632
chumaka@ccf.org
James  Hale  PhD James Hale, PhD
Fellow
Location:NN1-25
Phone:(216) 445-7632
halej2@ccf.org
Erin Elizabeth Mulkearns-Hubert  PhD Erin Elizabeth Mulkearns-Hubert, PhD
Fellow
Location:NN1-025
Phone:(216) 445-7632
mulkeae@ccf.org
Danny  Orabi  MD Danny Orabi, MD
PRISM Student
Location:NN1-25
Phone:(216) 445-7632
orabid@ccf.org
Natalia  Pokaleva  Natalia Pokaleva
Research Student
Location:NN1-25
Phone:(216) 445-7632
pokalen@ccf.org
Gustavo  Roversi  Gustavo Roversi
Research Student
Location:NN1-25
Phone:(216) 445-7632
roversf@ccf.org
Daniel  Silver  PhD Daniel Silver, PhD
Fellow
Location:NN1-125
Phone:(216) 445-7632
silverd2@ccf.org
Katie  Troike  Katie Troike
Graduate Student
Location:NN1-25
Phone:(216) 445-7632
troikek@ccf.org
Soumya  Turaga  Soumya Turaga
Graduate Student
Location:NN1-25
Phone:(216) 445-7632
turagas@ccf.org

1.        Lathia JD, Gallagher J, Myers JT, Vasanji A, McLendon RE, Hjelmeland AB, Huang AY, Rich JN, Direct in vivo evidence for tumor propagation by cancer stem cells,  PLoS One 2011, Sept 22

2.        Lathia JD, Heddleston JM, Venere M, Rich JN, Deadly teamwork: neural cancer stem cells and the tumor microenvironment, Cell Stem Cell 2011, 8(5):482-85

3.        Lathia JD, Gallagher J, Heddleston JM, Wang J, Eyler CE, MacSwords J, Wu Q, Vasanji A, McLendon RE, Hjelmeland AB, Rich JN, Integrin alpha 6 regulates brain tumor stem cells, Cell Stem Cell 2010, 6(5):421-32


01/16/2019 |  

Sex Differences Loom Large in Glioblastoma Development

Important sex differences are evident in many aspects of glioblastoma (GBM)—the most common and deadliest brain cancer—down to the cellular environment of the tumor. That was the central message delivered by Cleveland Clinic stem cell biologist Justin Lathia, PhD, at a symposium devoted to the topic at the Society of NeuroOncology annual meeting in November 2018. Such differences likely help explain the advantage that women have in terms of GBM incidence and prognosis, and these differences may provide important clues to developing more targeted and effective therapies.




02/08/2018 |  

How Cancer Stem Cells Drive Triple-Negative Breast Cancer

Hormone therapy for breast cancer blocks cancer cells from interacting with hormones such as estrogen and progesterone, which fuel the cells to grow and spread. Triple-negative breast cancer (TNBC) cells, however, lack the receptors needed to bind to these hormones and growth factors. Without such receptors, typical therapy does not work, contributing to poor survival rates for women with TNBC. 




08/31/2017 |  

New Breakthrough in Endometrial Cancer

For the past 25 years, standard therapy for endometrial and ovarian cancers has included surgery and the chemotherapy drug cisplatin. While these treatments typically are initially successful, the cancer often recurs and becomes resistant to cisplatin, leaving patients with limited treatment options.




02/07/2017 |  

Molecular Medicine Grad Authors Major Brain Cancer Publication

Alvaro Alvarado, PhD, a recent graduate of Lerner Research Institute's Molecular Medicine PhD program, has authored an important publication in Cell Stem Cell that uncovers how brain tumors are able to resist treatment.